----

-

---

THE EFFECT OF PRENATAL INJECTIONS OF
ADRENOCORTICOTROPIN AND GLUCOCORTICOID
ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE
AND GLYCOGEN IN NEONATAL RAT LIVER

A Thesis
Presented to
The Faculty of the School of Sciences and Mathematics
Morehead State University

In Partial Fulfillment
Of the Requirements for the Degree
Master of. Scien·ce in Biology

by

Zindoga Tiz J. Bungu
August, 1978

Accepted by the faculty of the School of Sciences
and Mathematics , Morehead State University , in partial
fulfillment of the requirements for the Master of Science
degree.

-----·- -

--

ABSTRACT
The effect of prenatal injections of adrenocorticotropin and glucocorticoid on glucose-6-phosphate
dehydrogenase and glycogen in neonatal rat liver.
Glycogen and_ glucose-6-phosphate dehydrogenas·e
(G6PD) levels were assayed in the livers of neonatal rats
whose mothers were injected during gestation with
adrenocorticotropin {ACTH) or a synthetic glucocorticoid,
dexamethasone.

Four to six newborn pups were selected

randomly and sacrificed within 12 hours of birth.

Body

weights and liver glycogen levels were significantly
decreased in neonatal rats subjected to maternal injections
of dexamethasone when compared to saline injected controls.
ACTH injections did not cause significant differences
from controls in body weights and glycogen levels.
Dexamethasone injections caused a slight decrease in
G6PD, but all treatments showed insignificant differences.
It is concluded that maternal glucocorticoids in the
doses used (800 µg/day), cross the placental tissues
and inversely affect the enzymes of the glycogenic and
_ glycogenolytic pathways.

ACTH in the dose used .(:i I. U ./day

was_not affective in eliciting this response through
maternal adrenal activation.
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INTRODUCTION
Claude Bernard (1859) demonstrated that glycogen is
stored in the fetal liver at a stage in gestation that is
characteristic of each species.

The glycogen content of

the rat fetal liver increases greatly during the last few
days of gestation (Bernard, 1859).

Jacquot and

Kretchmer (1964) determined that the change in glycogen
content in the rat fetal liver progresses gradually
between gestational days 15 and 18, and increases sharply
between 19 and 20 days of gestation.
Endocrine stimulation of glycogen deposition has
been suggested in numerous studies.

Jacquot and Kretchmer

(1964) indicated that the increase in glycogen deposition
in the rat is dependent upon hormonal stimulation and
does not occur when the fetus is deprived of adrenal
corticosteroids before day 19 of gestation.

Experiments

•in ·utero have shown that adrenal corticosteroids can
increase glycogen in fetal liver as early as the 15th day
of gestation (Greengard and Dewey, 1970).

The action of

adrenal corticoids in promoting deposition of glycogen in
the rat liver has also been documented by Wintenitz et al
(1957).

Jost (1961) and Jacquot (1959)

indicated that the.

glycogen accumulation during gestati-0n-is dependent on the
presence of both adrenal and pituitary or placental factors.
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There is a direct relationship between patterns of
enzymatic activities during devleopment and accumulation
of glycogen in the intact rat fetus (Jacquot and
Kretchmer, 1964).

Eisen et al (1973) proposed the

hypothesis that liver glycogen synthesis during the last
trimester requires both glucocorticoids and insulin for
the activation of glycogen synthetase.

Enzymatic

mechanisms involved in glucocorticoid induced glycogen
deposition have been proposed by Baxter and Forsham (1973).
These mechanisms _are illustrated in Figure 1.
Glucagon
+
Cyclic AMP
Glycogen

e

Phosphorylase a

Glvcogen Synt©tase

-· ©

e

[
G-1-P~ UDP
L---~Glucocorticoids

Insulin
Figure 1.

\£)

-------------t'------~
Glucose

Simpl:ified diagram of the scheme of the reactions
in glycogen formation and breakdown showing
stimulatory(+) and inhibitory (-) effects of
cyclic AMP, Insulin, Glucocorticoids and Glucose.
G-1-P = Glucose-1-phosphate. UDPG = Glycogen
phosphorylase a.
(Baxter and Forsham, 1972).
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Glucocorticoids activate glycogen synthetase through
activation of glycogen synthetase phosphatase, an enzyme
which removes phosphate from the inactive glycogen
synthetase.

This dephosphorylation activates the enzyme

glycogen synthetase.

Additionally, high glucose levels

activate glycogen synthetase through insulin stimulation
and directly inhibit the glycolytic enzyme, phosphorylase a.
Jacquot and Kretchmer (1964) determined the activities
of liver enzymes important in glycogen metabolism from
intact fetal rats as well as from fetal rats deprived of
corticoids by decapitation in utero.

They found that

storage of glycogen in liver of fetal rats seems to be
related to the relative inactivity of ·glucose-6-phosphate
(G6P), until almost term.

During the same time, the

glycogenic enzyme, glycogen synthetase, increases its
activity.

The major increase in gl~cogen synthetase

concentration and activity was found to occur between the
17th and 19th days-of gestation (Jacquot and Kretchmer
(1964).

They found that hepatic glucose-6-phosphate

dehydrogenase (G6PD) steadily decreased in activity so
that at 21 days of gestation, it was half the value
observed at 18 days of gestation.

Thus, an apparent

inverse relationship was suggested between the levels of
glycolytic enzymes and those enzymes of the glycogenic
pathway (Eisen et al, 1973; Jacquot and Kretchmer, 1964).

4

This observation is shown in Figure 2 which shows the
relationship glycogen deposition and the level of G6PD
in fetal rat liver.

It shows that as the level of G6PD

falls, the glycogen content rises.
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The developmental pattern of glucose-6phosphate dehydrogenase and concentration in_
liver of fetal rat.
Glycogen: bars; glucose6-phosphate dehydrogenase x
x.
(Modified
from Jacquot and Kretchmer, 1964).
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Figure 3 shows levels of G6PD in fetal rat livers of
unoperated controls and decapitated fetuses (Jacquot and
Kretchmer, 1964).

It is apparent that rats decapitated

in utero have increased G6PD levels over controls.
Jacquot and Kretcfuner (1964) suggest that decapitation
~n utero has the effect of preventing further differentiation of the pathway £or glycogen metabolism .
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Figure 3.

Effect of decapitation in utero .on activity
of glucose-6-phosphate dehydrogenase in
fetal rat liver. Decapitated rats, it
x;
Controls o----o.
(Jacquot and Kretchmer,
1964).
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Glucose-6-phosphate dehydrogenase was discovered by
Warburg in 1931.

It has been shown that G6PD activity is

inhibited by the RNA transcriptional inhibitor actinomycin
D and the protein translational inhibitor cycloheximide
(Keran and Barker, 1976).

The pentose phosphate pathway

begins with the dehydrogenation of G6P by nicotinamide
adenine dinucleotide phosphate (NADP) at carbon one (c-1),
a reaction catalyzed by G6PD (Stryer, 1975).

G6PD has

proved to be highly specific for NADP+ (Stryer, 1975).
The reaction catalyzed by G6PD is presented as follows:

NADP+

NADPH+H+

G-6-P-\...--°"----""""'/
_____) 6-Phosphoglucono-o-lactone
-_-G-6:-PD
G6PD mediates this reaction which is competitive to
glycogenesis (Eisen _et al, 1973).

G6PD catalyzed

oxidation of G-6-P is important for generating NADPH, a
hydrogen donor in liver biosynthesis pathways (Rouiller,
1964).

Pyridine linked dehydrogenases are evaluated by

determining the optical density change as NADP+ is
reduced.

Therefore the change in optical density as

G6PD reduces NADP+ is used to measure the concentration
of G6PD in the liver (Kaplan, 1966).

J

According to Jost and Tavernie_r (1956), the
-embryological development of the anterior pituitary
begins around 14.5 days of gestation in the rat fetus.
The general shape of the anterior pituitary is well
outlined by 16 to 17 days of gestation (Jost and
Tavernier, 1956)..

Thus, it is probable that ACTH

secretion starts after day 15 of gestation in the rat
fetus.

ACTH maintains the structure and enzyme activity

of the adrenal cortex (Mostafapour and Tchen, 1971).
Mostafapour and Tchen (1971) showed that ACTH stimulates
the rat zona fasciculata and zona reticularis to pr.educe
. glucocorticoids.

They showed that.the primary

glucocorticoid produced is corticosterone.

Sugihara and

Hajime "(1977) and Mazzocchi.et al (1976) showed that the
corticosterone is produced by the zona :fasciculata, and
tha_t the· increase .of_ certic9sterone :im the blood is
~t.rectly related to ACTH levels.

Glucocorticoids, in

turn, regulate ACTH release by a negative feedbac~
mechanism.through the pypothalamus.

Thus plasma

corticosterone levels are increased by ACTH injections
and decreased by exogenous glucocorticoid injections.
Normally, ACTH itself does not cross the placenta,
diminishing the likelihood of direct effects on the
fetus

(Milkovic et al, 1966).

Milkovic et al

(1973)

have pointed out that adrenal corticosterone of

8

maternal ori.gin and controlled by maternal ACTH crosses
th.e placenta and causes the effects on the fetal rat
liver.

Dexamethasone, a fluoronated synthetic

glucocorticoid (Figure 4), when injected into pregnant
rats, reduces maternal ACTH secretion and simultaneously
lowers blood-ACTH levels in rat fetuses

(Sugihara and

Hajime, 1977).

Dexarnetl,asone
Figure 4.

Corticosterone

The· structures of dexamethasone and
corticosterone.

Clearly, the above facts prove that injections of
ACTH and glucocorticoids to pregnant rats after the 14th
day of gestation or removal of these endogenous hormones
may influence fetal glycogen development.

In view of

the fact that effects of prenatal stress were mediated
by the maternal pi•tuitary-adrenocortical system
(Smith et al, 1975), the effects of both ACTH and
. glucocorticoids should be expressed in the offspring.
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Joffe (1977) found that ACTH did not affect birth weights
while dexamethasone injections produced a slight decrease
in birth weights.
The following study is an attempt to elaborate the
influence of G6PD and glucocorticoids on glycogen
deposition in the liver.

The effects of maternal

injections of ACTH and dexamethasone on the levels of
glycogen and G6PD in the liver of newborn rat pups was
studied.

MATERIALS AND METHODS
Animal Care and Tissue Preparation
Male and female rats of the Sprague-Dawley strain
(Harlan Industries, Inc.) were housed under a lighting
regimen of 12 hours light and 12 hours dark.

They were

given water and Purina Laboratory Chow (Ralston-Purina
Co.) ad libitum.

Tap water was given alternately with

an antibiotic drinking solution (Sulmet Drinking Solution,
American Cyanamid Co.).

The dosage of the antibiotic

drinking solution was 30 ml/3.8 liters of water.
Pregnant rats were obtained by placing one male in
a cage with. three females.

Vaginal smears were taken

each morning and the presence of sperm in the vagina was
used as the indicator for pregnancy.

The day sperm were

observed in the vaginal smears was taken as the first day
of pregnancy (day 1).
individually.

Pregnant females were hou_sed

The pregnant rats were divided in three

groups:
1.

Group one received 5 I.U/0.5 ml/day of ACTH
(Armour).

2.

Group two received 800 µg/0.2 cc/day of
Dexamethasone Sodium Phosphate (Dell
Laboratories, Inc.).

3.

Group three received 0.2 ml of 0.9% NaCl/day.

10
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All injections were given intramuscularly, ·.beginning on
day 15 of gestation and ending at parturition (day 22).
All analyses were performed within twelve (12)
hours after birth.

Four to six pups were.taken

randomly from each litter ,.;ind sexed.

The pups were

weighed in a preweighed beaker on a Sartorius Balance
(Sartorius Balances, Type 2492).

Each rat was killed

by decapitation and exsanguated.

The liver was exposed,

removed with scissor~and blotted before placing on an
ice block.

Each _liver was cut into halves.

One liver

half was added to a preweighed 15 ml round bottom test
tube containing 3 ml of potassium hydroxide (KOH) prior
to glycogen determination.

The other half was added to

a 15 ml cold homogenizer and washed in 5 ml of
homogenizing media (Physiological Saline + 6. 6 x 10- 4 M
EDTA; 25 mg EDTA-Na2 to 100 ml H 2 0.

Then it was

homogenized for 2 minutes in 2 ml of iced homogenizing
media using a Potter-]!:lvehjem Homogenizer.

The

homogenate-was decanted into a cold plastic centrifuge
tube.

The homogenizer was rinsed with 2 ml homogenizing

media which was added to original homogenate.

The

homogenate was centrifuged for 20 minutes at 1°C at
15000 r.p.m. in a Model B~20 International Refrigerated
Centrifuge (International· ·Equipment Co.).

After

centrifuging, ·.the supernatant was decanted into disposable
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test tubes (Lancer 12 x 75 mm Disposable Tube Polystyrene)
and kept on ice until assayed for G6PD.

G6PD Assay
G6PD was assayed with a Beckman DU-2 Spectrophotometer
(Beckman Instruments, Inc.) using the procedure of Lohr and
Waller.

Into each 3 ml Beckman cuvette, 2.4 ml

triethanolamine buffer (Sigma Chemical Co.); 0.5 ml
-2

NADPH

[3·x 102

.

M (25 mg NADPH in 1 ml 1% NaHCO 3 ) ] ; and
2

0.5 ml of the supernatant was added.

Each cuvette

contained supernatant from a different pup.

Then 0.05 ml

glucose-6-phosphate [4 x 10- 2 M (130 mg G6P-Na 2 in 10 ml
H2 O) (Sigma Chemical Co.)l was added to each cuvette, and
mixed quickly with the other reagents.

Optical density

(O.D.) readings were taken each minute for 10 minutes using
a wide slit width and a wavelength of 340 mµ.

The

average optical density (O.D.) change per minute was
calculated from these 10 readings.

The following

formuia was used to calculate the G6P-D units/ml serum:
llE 3 40 /min
0.001

= (llE 340 /min) x 1000 x dilution factor (2)
= G6P-D units/ml serum

~his formula is used with 1 ml supernatant in a 3 ml
assay mixture.

The usual definition of 1 unit of enzyme

activity according to the J.S. LaDue et al (1954) is the
amount of enzyme in 1 ml sample, which at 25°C in a 3 ml
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assay mixture,, changes the optical density of NADP at
340 mµ by 0. 001 in l min.
Glycogen· As·say
The determination of glycogen was by the Anthrone
Reagent Method (Carroll et al, 1956).

The liver half

in the test tube with 3 ml of KOH was digested in a
boiling water bath for 20-30 minutes.

The liver digest

was cooled, and the contents of each test tube were
transferred quantitatively to a SO ml volumetric flask
and diluted to SO ml with distilled water.
mixed thoroughly.

They were

A 0.4 ml aliquot of the solution

was finally diluted to 50 ml with distilled water in a
second 50 ml volumetric flask.

A 5 ml aliquot of each

final dilution was transferred to a 25 ml round-bottom
test tube.

Standards were prepared using 5 ml glucose

solution (containing 20 µg of glucose per ml), and a
blank was prepared with 5 ml distilled water.
tubes were put in a cold water bath.

All test

Ten milliliters

of Anthrone Reagent [(0.2µg Anthrone in 100 ml of 95%
H2SO4) (Fisher Scientific Co.) was pipetted into each
test tube.

The contents were mixed by agitation with

9" long disposable Pasteur pipettes (Fisher Scientific
Co.).

The cold test tubes were covered with glass

marbles and heated in a boiling-water bath.

At the end
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of 10 minutes , the test tubes were cooled immediate ly
i n a ice water bath .

The absorbancy of each tube was

read in a Spectronic- 20 Colorimete r
at 620 mµ

(Bausch and Lomb)

after the galvanometer had been set at 100

with the blank .

Calculations were made using the

formula :
100 XU
µ g of glycogen in aliquot =1 . 11 x s
where :

u

= the optical density of the unknown test
solution.

s = the optical d ensity of the 100- µg glucose
standard .
1 . 11 = the factor determined by Morris f or the
conversion of glucose to glycogen , with
this equation.

Protei n Assay
Protein was determined by t h e Lowry Method (1957).
A 0 . 5 ml aliquot of t h e supernatant from the G6PD assay
was transferred t o plastic centrifuge tubes and an
equa l vo l ume of 10 % trichloroacetic acid (TCA) was
added to precipitate the p r oteins .

The test tube s were

centrifJged at 20 , 000 r . p . m. for 10 minutes.
supe rnata nt was d e canted and discarded .

The

A 0 . 5 ml

aliquot of 3N sodium hydro xide (NaOH) was added to th e
pell e t and the solution was hydro l yzed in a boiling
water bath for 15 minutes .

1-5

Fifty microliters of each supernatant was put into
colorimetric tubes.

Standards containing O ml; 0.01 ml;

0.05 ml; 0.1 ml; and 0.2 ml of 1 mg/ml bovine serum
albumin (BSA) were run parallel to the samples.

All

colorimetric tubes were brought to a volume of 0.5 ml
with distilled water.

A 2.5 ml volume of a color reagent

(50 ml of 2% NaCO 3 in 0.1 N NaOH + 1 ml of 0.5% cuso~·
5 H 2 0 in 1% of Na+ or K+ tartrate), was mixed with each
tube and allowed to react for 30 minutes.

Then 0.25 ml

of a 1:1 dilution of commercial Polin and Ciocaltea's
reagent (Sigma Chemical Co.), was added.

Each tube was

vortexed and allowed to stand for 30 minutes.

Absorbancy

was read using wavelength of 7.50 nm and at constant time
inter.val with a colorimeter (Spectronic 70 by Bausch and
Lomb, 1977).

A curve was constructed from the standards

and the samples were read off the curve.

Protein

concentrations were expressed as milligram of protein.
Statistital Analysis
Statistical treatment was by analysis of variance
using the P.05 level.

Significance between means was

evaluated using the Duncan's New Multiple Range Test.
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RESULTS
The comparative effects of injections of ACTH
dexamethasone and saline injected controls on neonatal
body weights is shown in Figure 5.

The differences in

body weight in the three treatments were significant
as shown by analysis of variance at the P.05 level
(calculated F=l6.69 > tabulated F=3.15) for 2 and
57 degrees of freedom.

Duncan's New Multiple Range

Test (Duncan's NMRT) showed a significant decrease in
neonatal weights of pups of dexamethasone treated rats
as compared to both those of the ACTH treated and the
controls.

But there was no significant difference

between ACTH treated and saline injected rats.
Figure 6 shows the effect of prenatal injections
of dexamethasone, ACTH, and saline on neonatal amount
of glycogen in the neonatal rat liver.

Analysis of

variance showed a significant F of 8.34 (tabulated
F=3.15).

Duncan's NMRT showed that the amount of

glycogen in livers of pups of dexamethasone treated

'
mothers is significantly higher than that in livers
of pups of both ACTH, and saline treated mothers.
But the difference in amount of glycogen in livers
of !?UPS of ACTH, and saline treated rats was not
significant.
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Both the analysis of variance and Duncan's NMRT
showed that the differences in the amount of G6PD
between treatments were insignificant.

The analysis

of variance at the P.05 level showed a nonsignificant
F of 2.09 (tabulated F=3.15).

The effect of prenatal

injections of dexamethasone, ACTH, and saline on
neonatal amount of G6PD in rat fetuses is shown in
Figure 7.
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DISCUSSION
Glucocorticoids have a catabolic effect on many
of the tissues of the body and an anabolic effect on the
liver.

Thus tissues such as muscle, skin, lymphoid, and

adipose respond to glucocorticoids by decreased
synthesis and increased degradation of protein, fat,
RNA and DNA, and decreased uptake of glucose and amino
acids (Baxter and Forsham, 1972).

In this studY,

excessive injections of dexamethasone into pregnant rats
the last trimester of pregnancy demonstrated a significant
decrease in the body weight of neonatal pups, when
compared to saline injected controls (Figure 5).

The well

known activation of gluconeogenic pathways and inhibition
of glucose and amino acid uptake are suggested causes for
growth inhibition.

Figure 5 also shows that maternal

ACTH injections were not effective on the body weights of
neonatal pups.

This evidence concurs with the research

of Joffe (1977) which indicated that ACTH did not effect
birth weights while dexamethasone injections produced a
slight decrease in birth weights of pups.
An apparent inverse relationship was suggested
between the levels of glycolytic enzymes and those of the
glycogenic pathway (Eisen et al, 1973; Jacquot and
Kretchmer, 1964).

Thus, it was reported that as liver
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_glycogen levels increased from gestational days 17 to 21,
G6J?D concentration fell {Jacquot and Kretchmer, 1964).
Although this study did not examine enzymes of the
glycogenic pathway, glycogen deposition was measured as
an indicator of glycogen synthetase activity.

Glycogen·

levels were significantly greater in the liver of
neonatal pups from pregnant dams injected with dexamethasone
in the last trimester of pregnancy (Figure 6).

This effect

by glucocorticoids substantiates the reported role that
adrenal corticoids stimulate glycogen deposition by
activation of glycogen synthetase (Baxter and Forsham,
1972).

Dexamethasone may be more effective in glycogen

·deposition since it is not metabolized as rapidly as
endogenous glucocorticoids.
G6PD levels were not significantly affected by
dexamethasone injections.

This is in contradiction to

results published by Jacquot and Kretchmer (1964).

This

contradiction may be due to the fact that Jacquot and
Kretchmer examined the fetuses just before they were born,
while in the present study the examination was done
between one and twelve hours after birth.

However, the

correlation that glycogen and G6PD levels are inversely
related is supported by the results of this study (Figures
6 and 7).

Thu~ the dexamethasone treated rats which

showed a lower G6PD level than controls (Figure 7),
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inversely showed a significantly higher content of liver
glycogen.
Milkovic et al (1966) found that ACTH does not cross
the placental barrier, thus negating the direct effect of
ACTH on the fetus.

However, ACTH in the maternal plasma

stimulates maternal adrenal glucorticoid release which
can cross the placenta to stimulate the fetal rat liver
(Milkovic et al, 1973).

ACTH injections into pregnant

rats showed a non-significant elevation of neonatal liver
and glycogen and G6PD from saline injected controls
(Figure 6 and 7).

This insignificant increase may be

explained by an insufficient dose of ACTH, by the
·inactivation of ACTH prior to maternal adrenal stimulation,
or by the inactivation of adrenal corticoids by maternal
and/or fet~l liver.
The conclusion of these experiments is that maternal
injections of dexamethasone,btitnot ACTH, in the doses used,
significantly depressed body weight and elevated liver
glycogen, but did not effect liver G6PD levels in newborn
rats,

Therefore, the adrenal cortex of the mother may

serve as an important regulator of fetal development,
specifically glycogen deposition.
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